Global Non-Invasive Prenatal Testing (NIPT) Market - 2025-2033

September 2025 | 69 pages | ID: G36D4F41633FEN
DataM Intelligence

Abstracts

Global Non-Invasive Prenatal Testing (NIPT) Market reached US$ 6.31 billion in 2023 and is expected to reach US$ 22.41 billion by 2033, growing with a CAGR of 13.20% during the forecast period 2026-2033.

The Global Non-Invasive Prenatal Testing (NIPT) Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Global Non-Invasive Prenatal Testing (NIPT) Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product Type

• Instruments*
• Consumables & Reagents

By Test Type

• MaterniT21*
• Harmony
• Panorama
• Others

By Method

• Ultrasound Detection*
• Biochemical Screening Tests
• Cell-Free DNA In Maternal Plasma

By Application

• Trisomy (Down Syndrome, Edwards Syndrome, Patau Syndrome)*
• Microdeletion Syndrome
• Others

By End User

• Diagnostic Laboratories*
• Hospitals
• Clinics

Regional Analysis for Global Non-Invasive Prenatal Testing (NIPT) Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Global Non-Invasive Prenatal Testing (NIPT) Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Test Type
2.5. Snippet by Method
2.6. Snippet by Application
2.7. Snippet by End User
2.8. Snippet by Region

3. DYNAMICS

3.1. Impacting Factors
  3.1.1. Drivers
    3.1.1.1. Rising Prevalence of Chromosomal Abnormalities in Newborns
    3.1.1.2. Growing Preference for Non-Invasive Testing Over Invasive Procedures
  3.1.2. Restraints
    3.1.2.1. High Cost of NIPT Procedures
    3.1.2.2. Limited Awareness and Access in Emerging Economies
  3.1.3. Opportunity
    3.1.3.1. Technological Advancements in Genomic Sequencing and Bioinformatics
    3.1.3.2. Expanding Adoption of NIPT in Emerging Markets
  3.1.4. Impact Analysis

4. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

4.1. Market Leaders and Pioneers
  4.1.1. Emerging Pioneers and Prominent Players
  4.1.2. Established leaders with largest largest-selling Brand
  4.1.3. Market leaders with established products & Services
4.2. Product Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
  4.3.1. North America
  4.3.2. Europe
  4.3.3. Asia Pacific
  4.3.4. South America
  4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics

5. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET: BY PRODUCT TYPE

5.1. Introduction
  5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  5.1.2. Market Attractiveness Index, By Product Type
5.2. Instruments*
  5.2.1. Introduction
  5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Consumables & Reagents

6. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET: BY TEST TYPE

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  6.1.2. Market Attractiveness Index, By Test Type
6.2. MaterniT21*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Harmony
6.4. Panorama
6.5. Others

7. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET: BY METHOD

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  7.1.2. Market Attractiveness Index, By Method
7.2. Ultrasound Detection*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Biochemical Screening Tests
7.4. Cell-Free DNA In Maternal Plasma

8. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET: BY APPLICATION

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  8.1.2. Market Attractiveness Index, By Application
8.2. Trisomy (Down Syndrome, Edwards Syndrome, Patau Syndrome)*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Microdeletion Syndrome
8.4. Others

9. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET: BY END USER

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  9.1.2. Market Attractiveness Index, By End User
9.2. Diagnostic Laboratories*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Hospitals
9.4. Clinics

10. GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  10.1.2. Market Attractiveness Index, By Region
10.2. North America
  10.2.1. Introduction
  10.2.2. Key Region-Specific Dynamics
  10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.2.8.1. U.S.
    10.2.8.2. Canada
    10.2.8.3. Mexico
10.3. Europe
  10.3.1. Introduction
  10.3.2. Key Region-Specific Dynamics
  10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.3.8.1. Germany
    10.3.8.2. U.K.
    10.3.8.3. France
    10.3.8.4. Spain
    10.3.8.5. Italy
    10.3.8.6. Rest of Europe
10.4. South America
  10.4.1. Introduction
  10.4.2. Key Region-Specific Dynamics
  10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
  10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    10.4.8.1. Brazil
    10.4.8.2. Argentina
    10.4.8.3. Rest of South America
  10.4.9. Asia-Pacific
    10.4.9.1. Introduction
    10.4.9.2. Key Region-Specific Dynamics
    10.4.9.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    10.4.9.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    10.4.9.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
    10.4.9.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    10.4.9.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    10.4.9.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      10.4.9.8.1. China
      10.4.9.8.2. India
      10.4.9.8.3. Japan
      10.4.9.8.4. South Korea
      10.4.9.8.5. Rest of Asia-Pacific
  10.4.10. Middle East and Africa
    10.4.10.1. Introduction
    10.4.10.2. Key Region-Specific Dynamics
    10.4.10.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    10.4.10.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
    10.4.10.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
    10.4.10.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    10.4.10.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

11.1. Competitive Overview and Key Market Players
11.2. Market Share Analysis and Positioning Matrix
11.3. Strategic Partnerships, Mergers & Acquisitions
11.4. Key Developments in Product Portfolios and Innovations
11.5. Company Benchmarking

12. COMPANY PROFILES

12.1. Illumina, Inc*
  12.1.1. Company Overview
  12.1.2. Product Portfolio
    12.1.2.1. Product Description
    12.1.2.2. Product Key Performance Indicators (KPIs)
    12.1.2.3. Historic and Forecasted Product Sales
    12.1.2.4. Product Sales Volume
  12.1.3. Financial Overview
    12.1.3.1. Company Revenue
    12.1.3.2. Geographical Revenue Shares
    12.1.3.3. Revenue Forecasts
  12.1.4. Key Developments
    12.1.4.1. Mergers & Acquisitions
    12.1.4.2. Key Product Development Activities
    12.1.4.3. Regulatory Approvals, etc.
    12.1.4.4. SWOT Analysis
12.2. Natera, Inc.
12.3. F. Hoffmann-La Roche Ltd.
12.4. BGI Genomics Co., Ltd.
12.5. Laboratory Corporation of America Holdings (LabCorp)
12.6. Qiagen N.V.
12.7. Eurofins Scientific
12.8. Agilent Technologies, Inc.
12.9. Myriad Genetics, Inc. (LIST NOT EXHAUSTIVE)

13. ASSUMPTIONS AND RESEARCH METHODOLOGY

13.1. Data Collection Methods
13.2. Data Triangulation
13.3. Forecasting Applications
13.4. Data Verification and Validation

14. APPENDIX

14.1. About Us and Services
14.2. Contact Us